Notice: This company has been marked as potentially delisted and may not be actively trading. Axonics (AXNX) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Axonics Short Interest DataAxonics (AXNX) has a short interest of 3.31 million shares. This marks a 5.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.5, indicating that it would take 8.5 days of the average trading volume of 713,457 shares to cover all short positions.Current Short Interest3,310,000 sharesPrevious Short Interest3,140,000 sharesChange Vs. Previous Month+5.41%Dollar Volume Sold Short$232.69 millionShort Interest Ratio8.5 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares51,110,000 sharesPercentage of Shares Shorted6.48%Today's Trading Volume4,233,300 sharesAverage Trading Volume713,457 sharesToday's Volume Vs. Average593% Short Selling Axonics? Sign up to receive the latest short interest report for Axonics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAXNX Short Interest Over TimeAXNX Days to Cover Over TimeAXNX Percentage of Float Shorted Over Time Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Axonics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20243,310,000 shares $232.69 million +5.4%N/A8.5 $70.30 10/15/20243,140,000 shares $220.68 million -12.8%N/A8.2 $70.28 9/30/20243,600,000 shares $250.56 million +4.7%N/A9.8 $69.60 9/15/20243,440,000 shares $236.78 million -1.2%N/A10.1 $68.83 8/31/20243,480,000 shares $240.69 million +5.8%N/A10.3 $69.17 8/15/20243,290,000 shares $226.48 million +1.5%N/A9.7 $68.84 Get the Latest News and Ratings for AXNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Axonics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20243,240,000 shares $221.88 million No ChangeN/A9.2 $68.48 7/15/20243,240,000 shares $219.83 million -4.7%N/A8.6 $67.85 6/30/20243,400,000 shares $228.58 million +0.6%N/A7.8 $67.23 6/15/20243,380,000 shares $227.14 million -2.6%N/A5.8 $67.20 5/31/20243,470,000 shares $232.80 million -3.3%N/A5.4 $67.09 5/15/20243,590,000 shares $243.01 million +5.3%N/A4.9 $67.69 4/30/20243,410,000 shares $227.00 million -15.6%N/A4.1 $66.57 4/15/20244,040,000 shares $272.01 million +17.4%N/A4.4 $67.33 3/31/20243,440,000 shares $237.26 million +17.0%N/A2.5 $68.97 3/15/20242,940,000 shares $199.36 million +4.3%N/A2.3 $67.81 2/29/20242,820,000 shares $191.59 million +6.4%N/A2.3 $67.94 2/15/20242,650,000 shares $179.94 million -1.1%N/A2.3 $67.90 1/31/20242,680,000 shares $181.92 million +131.0%N/A2.4 $67.88 1/15/20241,160,000 shares $79.72 million -55.4%N/A1.1 $68.72 12/31/20232,600,000 shares $161.80 million -4.1%N/A3.2 $62.23 12/15/20232,710,000 shares $157.94 million +16.3%N/A5.1 $58.28 11/30/20232,330,000 shares $130.46 million +7.9%N/A4.2 $55.99 11/15/20232,160,000 shares $123.60 million -22.0%N/A3.9 $57.22 10/31/20232,770,000 shares $141.85 million -0.7%N/A4.4 $51.21 10/15/20232,790,000 shares $147.87 million -10.3%N/A4.2 $53.00 9/30/20233,110,000 shares $174.53 million +1.0%N/A4.5 $56.12 9/15/20233,080,000 shares $182.15 million -0.3%N/A4.4 $59.14 8/31/20233,090,000 shares $177.06 million +7.7%N/A4.4 $57.30 8/15/20232,870,000 shares $179.40 million -18.0%N/A4.1 $62.51 7/31/20233,500,000 shares $211.30 million -10.3%N/A5.3 $60.37 7/15/20233,900,000 shares $202.92 million +2.6%N/A6.1 $52.03 6/30/20233,800,000 shares $191.79 million -5.5%N/A6.7 $50.47 6/15/20234,020,000 shares $210.57 million -1.2%N/A6.9 $52.38 5/31/20234,070,000 shares $196.95 million -2.2%N/A6.8 $48.39 5/15/20234,160,000 shares $224.72 million +1.0%N/A6.6 $54.02 4/30/20234,120,000 shares $236.74 million -1.0%N/A6.6 $57.46 4/15/20234,160,000 shares $238.45 million +2.7%N/A7.4 $57.32 3/31/20234,050,000 shares $220.97 million +5.7%N/A6.2 $54.56 3/15/20233,830,000 shares $204.71 million -2.5%N/A5.7 $53.45$20k in extra income? (Ad)My friend Alex Reid just might have created my favorite strategy right now. You see, Alex has figured out how to cut-the-corner so to speak, and be one of the laziest traders possible…. While still showing his traders how to target big money. This past year, his LIVE “lazy trade” alerts have delivered impressive results—and that’s only a fraction of the opportunities he’s shared. And that’s just just a quarter of the total trade alerts he’s sent out. The true total profit potential his beta-testers have had the chance to target is far larger than $20k. Alex recorded a special video training where he reveals exactly how much. 2/28/20233,930,000 shares $236.15 million +1.6%N/A5.9 $60.09 2/15/20233,870,000 shares $222.91 million +10.9%N/A6.2 $57.60 1/31/20233,490,000 shares $214.29 million -1.4%N/A5.5 $61.40 1/15/20233,540,000 shares $229.68 million -3.0%N/A5.2 $64.88 12/30/20223,650,000 shares $228.23 million +13.7%N/A5.9 $62.53 12/15/20223,210,000 shares $191.19 million No ChangeN/A5.5 $59.56 11/30/20223,210,000 shares $219.82 million No ChangeN/A5.3 $68.48 11/15/20223,210,000 shares $206.66 million -3.0%N/A5.2 $64.38 10/31/20223,310,000 shares $242.09 million -8.3%N/A5.2 $73.14 10/15/20223,610,000 shares $240.17 million -2.7%N/A5.4 $66.53 9/30/20223,710,000 shares $261.33 million -7.7%N/A5.7 $70.44 9/15/20224,020,000 shares $313.48 million -6.5%N/A6.1 $77.98 8/31/20224,300,000 shares $310.68 million +5.4%N/A6.8 $72.25 8/15/20224,080,000 shares $300.86 million +0.3%N/A6.8 $73.74 7/31/20224,070,000 shares $264.02 million -3.1%N/A6.4 $64.87 7/15/20224,200,000 shares $266.53 million -0.7%10.1%7.5 $63.46 6/30/20224,230,000 shares $239.71 million -5.4%10.2%7.5 $56.67 6/15/20224,470,000 shares $226.67 million +2.5%10.8%8.3 $50.71 5/31/20224,360,000 shares $218 million +0.5%11.0%8.5 $50.00 5/15/20224,340,000 shares $205.24 million +0.2%11.0%8.1 $47.29 4/30/20224,330,000 shares $224.38 million +1.4%11.0%8.9 $51.82 4/15/20224,270,000 shares $272.47 million +3.1%10.8%9.6 $63.81 3/31/20224,140,000 shares $259.16 million -2.1%10.5%8.9 $62.60 3/15/20224,230,000 shares $216.07 million +2.2%11.2%8.9 $51.08 2/28/20224,140,000 shares $234.99 million -4.8%11.2%8.1 $56.76 2/15/20224,350,000 shares $236.51 million +6.9%11.7%8.2 $54.37 1/31/20224,070,000 shares $193.04 million -10.0%11.0%7.4 $47.43 1/15/20224,520,000 shares $243.45 million -2.4%12.1%8.2 $53.86 12/31/20214,630,000 shares $259.28 million -1.1%12.5%8.7 $56.00 12/15/20214,680,000 shares $242.00 million -7.5%12.6%9.1 $51.71 11/30/20215,060,000 shares $275.31 million +2.6%13.6%9.7 $54.41 11/15/20214,930,000 shares $291.26 million +14.1%13.3%10 $59.08 10/29/20214,320,000 shares $316.87 million -8.7%11.6%8.8 $73.35 10/15/20214,730,000 shares $298.75 million -5.0%12.7%9.6 $63.16 9/30/20214,980,000 shares $324.15 million +14.8%13.4%9.9 $65.09 9/15/20214,340,000 shares $306.06 million +6.4%11.7%8.3 $70.52 8/31/20214,080,000 shares $305.92 million -4.0%11.0%8.2 $74.98 8/13/20214,250,000 shares $281.95 million +3.7%11.5%8.4 $66.34 7/30/20214,100,000 shares $278.60 million -9.1%11.1%7.4 $67.95 7/15/20214,510,000 shares $269.25 million -0.4%12.8%8.5 $59.70 6/30/20214,530,000 shares $287.25 million +7.9%12.9%8.5 $63.41 6/15/20214,200,000 shares $244.78 million +5.8%12.0%8 $58.28 5/28/20213,970,000 shares $229.03 million -1.7%11.3%7.7 $57.69 5/14/20214,040,000 shares $207.62 million -3.1%N/A6.9 $51.39 4/30/20214,170,000 shares $260.04 million -1.0%N/A8.1 $62.36 4/15/20214,210,000 shares $252.35 million -2.3%N/A7.5 $59.94 3/31/20214,310,000 shares $248.47 million -1.8%N/A7.6 $57.65 3/15/20214,390,000 shares $255.15 million -2.2%N/A7.5 $58.12 2/26/20214,490,000 shares $228.18 million -4.5%N/A8 $50.82 2/12/20214,700,000 shares $257.42 million -9.3%N/A9.3 $54.77$20k in extra income? (Ad)My friend Alex Reid just might have created my favorite strategy right now. You see, Alex has figured out how to cut-the-corner so to speak, and be one of the laziest traders possible…. While still showing his traders how to target big money. This past year, his LIVE “lazy trade” alerts have delivered impressive results—and that’s only a fraction of the opportunities he’s shared. And that’s just just a quarter of the total trade alerts he’s sent out. The true total profit potential his beta-testers have had the chance to target is far larger than $20k. Alex recorded a special video training where he reveals exactly how much. 1/29/20215,180,000 shares $276.77 million +1.0%19.0%9.2 $53.43 1/15/20215,130,000 shares $270.61 million -4.3%19.3%9.3 $52.75 12/31/20205,360,000 shares $262.05 million -7.3%20.2%10.8 $48.89 12/15/20205,780,000 shares $249.75 million +6.3%21.8%10.8 $43.21 11/30/20205,440,000 shares $249.10 million +4.4%20.5%9.7 $45.79 11/15/20205,210,000 shares $238.67 million +1.2%19.7%9.1 $45.81 10/30/20205,150,000 shares $251.68 million -4.5%19.5%9.4 $48.87 10/15/20205,390,000 shares $259.47 million -8.6%20.6%10 $48.14 9/30/20205,900,000 shares $301.14 million +1.9%22.5%10.4 $51.04 9/15/20205,790,000 shares $241.91 million +8.6%22.1%10.1 $41.78 8/31/20205,330,000 shares $225.25 million -0.2%20.3%9.2 $42.26 8/14/20205,340,000 shares $229.83 million +1.0%20.8%9.4 $43.04 7/31/20205,290,000 shares $224.08 million +1.0%24.7%8.8 $42.36 7/15/20205,240,000 shares $193.78 million -3.0%24.4%8 $36.98 6/30/20205,400,000 shares $186.30 million +35.7%25.3%8.2 $34.50 6/15/20203,980,000 shares $143.20 million No Change18.6%6.5 $35.98 5/29/20203,980,000 shares $145.95 million -7.7%18.6%6 $36.67 5/15/20204,310,000 shares $154.34 million -2.7%22.2%6 $35.81 4/30/20204,430,000 shares $149.56 million -4.7%20.1%6.3 $33.76 4/15/20204,650,000 shares $138.15 million -4.7%27.4%7.4 $29.71 3/31/20204,880,000 shares $170.41 million +0.9%28.8%6.8 $34.92 3/13/20204,836,200 shares $137.06 million -16.0%54.3%6.2 $28.34 2/28/20205,760,000 shares $105.81 million +17.8%64.7%8.1 $18.37 2/14/20204,890,000 shares $156.63 million -4.5%29.4%7 $32.03 1/31/20205,120,000 shares $187.14 million -0.6%31.9%7.1 $36.55 1/15/20205,150,000 shares $162.48 million -3.6%32.6%7.2 $31.55 12/31/20195,340,000 shares $163.35 million +12.0%34.5%7.8 $30.59 AXNX Short Interest - Frequently Asked Questions What is Axonics' current short interest? Short interest is the volume of Axonics shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 3,310,000 shares of AXNX short. Learn More on Axonics' current short interest. What is a good short interest ratio for Axonics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXNX shares currently have a short interest ratio of 8.0. Learn More on Axonics's short interest ratio. Which institutional investors are shorting Axonics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Axonics: Centiva Capital LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Axonics' short interest increasing or decreasing? Axonics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 3,310,000 shares, an increase of 5.4% from the previous total of 3,140,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Axonics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to Axonics: Solventum Co. (3.04%), Smith & Nephew plc (0.70%), Penumbra, Inc. (4.64%), Glaukos Co. (4.66%), Bausch + Lomb Co. (3.48%), Stevanato Group S.p.A. (6.59%), Inspire Medical Systems, Inc. (7.74%), PROCEPT BioRobotics Co. (11.99%), NovoCure Limited (5.33%), Envista Holdings Co. (6.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Axonics stock? Short selling AXNX is an investing strategy that aims to generate trading profit from Axonics as its price is falling. AXNX shares are trading up $0.53 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Axonics? A short squeeze for Axonics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AXNX, which in turn drives the price of the stock up even further. How often is Axonics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXNX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies SOLV Short Interest SNN Short Interest PEN Short Interest GKOS Short Interest BLCO Short Interest STVN Short Interest INSP Short Interest PRCT Short Interest NVCR Short Interest NVST Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AXNX) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axonics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axonics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
